Strides Pharma Income Statement

Quarterly

Yearly

home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
20212022
EBITDA686112
EBIT523-365
Earning Per Share28-51
Expenses2,6893,090
Net Profit356-363
Net Profit Margin10-12
Operating Profit Margin214
Profit Before Tax373-542
Dividends Per Share30
Operation Revenue3,3753,202

Peer Comparison (in ₹.Cr.)

CompanyYearEBITEBITDANet ProfitNet WorthProfit Before Tax
2023008,560.84NA9,408.43
2023002,835.49NA4,038.35
202300372.90NA385.50
202300103.87NA140.39
20221,257.602,182.90978.507,628.101,190
The EBITDA of Strides Pharma is 112 as of 9/24/2023
home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
20112011201120112021
Operating Activities457457457457481
Investing Activities-656-656-656-656-521
Financing Activities89898989-16
Others00000
Net Cash Flow-110-110-110-110-55

Peer Comparison (in ₹.Cr.)

CompanyYearOperating ActivitiesInvesting ActivitiesFinancing ActivitiesNet Cash Flow
20234,959.33-7,943.682,376.07-608.28
20223,325.90-1,871.88-1,599.79-145.77
2023723.95-447.59-261.9614.40
2020140.90-44.50-38.5557.85
2017640-498.50-177.50-36
The cash flow from Operating Activities of Strides Pharma is 481 as of 9/24/2023